This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Omnicell to Buy Ateb, Expand in Adherence Tools Market
by Zacks Equity Research
Omnicell, Inc. (OMCL) recently inked a deal to buy pharmacy-based patient care solution provider Ateb, Inc and its Canadian affiliate, Ateb Canada Ltd.
Medtronic Stock Falls on Mixed 2Q; Positive on HeartWare Buy
by Zacks Equity Research
On Nov 30, 2016, we issued an updated research report on medical device major, Medtronic plc (MDT).
Medtronic Partners UH to Launch Integrated Health Solutions
by Zacks Equity Research
Medtronic plc (MDT) recently announced the signing of its Integrated Health Solutions agreement with University Hospitals (UH) in the U.S.
Medtronic's Less-Invasive HVAD Implant System Gets CE Mark
by Zacks Equity Research
Medtronic plc (MDT) recently announced the receipt of CE mark for its HVAD System left ventricular assist device (LVAD) for patients with advanced heart failure.
NuVasive: Q3 Results Lack Shine, Spine Market Holds Promise
by Zacks Equity Research
On Nov 28, we issued an updated research report on San Diego, CA-based NuVasive, Inc. (NUVA).
Bear of the Day: Abaxis (ABAX)
by Jeremy Mullin
Poor earnings and falling estimates among reasons to avoid Abaxis.
OSI Systems, Kirby, Baxter International, ST Microelectronics and EQT Midstream Partners highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
OSI Systems, Kirby, Baxter International, ST Microelectronics and EQT Midstream Partners highlighted as Zacks Bull and Bear of the Day
New Research Reports for Microsoft, Caterpillar & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Caterpillar (CAT), Microsoft (MSFT) and Thermo Fisher (TMO).
Bull of the Day: Baxter International (BAX)
by Jeremy Mullin
A string of EPS beats has Baxter outperforming.
Lots Happening in MedTech: Should You Buy These Stocks?
by Zacks Equity Research
We have noticed a substantial transformation in the U.S. medical device market of late and it is important for market participants to adapt. We have hit upon3 major evolving trends in this sector.